Anlotinib inhibits cervical cancer cell proliferation and invasion by suppressing cytokine secretion in activated cancer-associated fibroblasts

HIGHLIGHTS

• What: The aim of this study was to verify whether anlotinib inhibits CAFs derived from cervical cancer tissues. The authors identified that anlotinib inhibited the activation of CAFs and significantly suppressed the expression of several cytokines, especially IL-6, IL-8, VEGF and TNF-a.
• Who: CAFs and colleagues from the National Institute (NIH), United States Yonsei University, Republic of Korea have published the paper: Anlotinib inhibits cervical cancer cell proliferation and invasion by suppressing cytokine secretion in activated cancer- associated fi broblasts, in the Journal: (JOURNAL)
• How: Promote the proliferation and invasion . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.